niclosamide has been researched along with B16 Melanoma in 1 studies
Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Niclosamide is an FDA-approved and old anti-helminthic drug used to treat parasitic infections." | 1.51 | Nanoliposomal Encapsulation Enhances ( Hatamipour, M; Jaafari, MR; Momtazi-Borojeni, AA; Ramezani, M; Sahebkar, A, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hatamipour, M | 1 |
| Jaafari, MR | 1 |
| Momtazi-Borojeni, AA | 1 |
| Ramezani, M | 1 |
| Sahebkar, A | 1 |
1 other study available for niclosamide and B16 Melanoma
| Article | Year |
|---|---|
Nanoliposomal Encapsulation Enhances
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Carriers; Drug Compounding; Liposomes; Male; | 2019 |